139 hasil
Menampilkan 1–20 · 0,27 detik · RSS
Glioma
ISSN 2589-6113 · Wolters Kluwer Medknow Publications · 139 artikel di indeks
-
Artikel Jurnal
Establishment and validation of glioma patient-derived organoid models
Background and Aim: Glioma is one of the most prevalent and refractory brain cancers with a high recurrence rate. Current limitations of experimental in vitro models include their inability to remodel the heterogeneity of the parental tumors and their incapacity to effectively reflect antitumor…
-
Artikel Jurnal
Intracranial multiple glioblastomas resembling metastases: A case report
The diagnosis and treatment of gliomas have traditionally been both a research hotspot and a challenge in clinical medicine. Intracranial multiple gliomas are rare, and their diagnosis and treatment are often more difficult than those of solitary gliomas. In this article, we report our experience…
-
Artikel Jurnal
Revisiting glioblastoma classification through an immunological lens: A narrative review
Glioblastoma (GBM) is characterized by a high recurrence rate, significant heterogeneity, and poor prognosis. While there has been a shift in recent years to focus on molecular phenotyping, there are limited data regarding the relationship between the immune milieu and heterogeneous molecular…
-
Artikel Jurnal
Molecular landscape of glucose metabolism in glioblastoma and the normal human brain: A narrative review
Glioblastoma multiforme (GBM) is one of the most aggressive tumors known to occur in the brain. Metabolism is one of the driving factors enabling the successful proliferation of tumor cells, thus increasing the tumor mass. Tumor metabolism is now recognized as a major hallmark of oncogenesis. Since…
-
Artikel Jurnal
Gliosarcoma in a patient with triple-negative breast cancer: A case report
Gliosarcoma is a rare subtype of glioblastoma with the histological features of both glioblastoma and soft-tissue sarcoma. Triple-negative breast cancer (TNBC) is a special type of breast cancer that is different from other breast cancers. It is characterized by strong invasiveness, high recurrence…
-
Artikel Jurnal
Glioblastoma in an old patient treated with a combination of tumor-treating fields and standard chemoradiotherapy: A case report
Glioblastoma (GBM) is the most common type of primary brain tumor in adults. Due to the lack of clinical data, there is no standard treatment for GBM in old patients, and the prognosis is poor. We report a case of a 69-year-old female patient diagnosed with GBM who received tumor resection…
-
Artikel Jurnal
Elevated Fras1-related extracellular matrix 3 in isocitrate dehydrogenase 1-mutant astrocytoma World Health Organization grade 4 predicts favorable prognosis in glioma: A bioinformatic and experimental analysis
Background and Aim: World Health Organization (WHO) grade 4 glioma is a malignancy of the central nervous system characterized by refractoriness to treatment and a high mortality rate. Isocitrate dehydrogenase (IDH) mutation is a crucial molecular event for the classification of glioma and…
-
Artikel Jurnal
Current status of clinical application of immunotherapy in the treatment of glioma: A narrative review
Glioma is a common type of brain tumor. Current treatment for glioma includes surgical resection, radiotherapy, chemotherapy, and tumor-treating fields. The application of immunotherapy to treat glioma is still far from satisfactory in the clinic. Here, we review the mechanisms of immunotherapy for…
-
Artikel Jurnal
Research progress in the treatment of glioblastoma by an oncolytic virus: A narrative review
Glioblastoma is the most common malignant tumor in the adult primary central nervous system. It has a strong proliferative ability, high recurrence rate, and high malignant degree. Despite standard radiotherapy combined with temozolomide chemotherapy, the prognosis was poor, with a 5-year survival…
-
Artikel Jurnal
Tumor growth, angiogenesis, and invasion as clinical hallmarks of glioblastoma: A case report
The clinical hallmarks of tumor growth, angiogenesis, and invasion were identified in a patient with isocitrate dehydrogenase-1 wild-type glioblastoma at initial diagnosis and management issues were examined. The head magnetic resonance imaging (MRI) showed multiple solid and cystic contrast…
-
Artikel Jurnal
Overcoming T-cell exhaustion in glioblastoma: A narrative review
Immunotherapy is typically ineffective against glioblastoma (GBM) due to inherent and adaptive resistance. Initial immunotherapy results for GBM have been disappointing. In this regard, T-cell exhaustion is a major barrier to successful treatment. The recognition of exhausted CD8+ T cell (Tex)…
-
Artikel Jurnal
Interactive relationship between neuronal circuitry and glioma: A narrative review
Glioma is the most common primary central nervous system tumor. Despite extensive basic research on the tumor, the overall therapeutic effect of glioma remains unsatisfactory. Glioma grows within the framework of complex neural circuitry, which influences both neural network and tumor biology. On…
-
Artikel Jurnal
Associations of O6-methylguanine-DNA methyltransferase promoter methylation status with age and 1p/19q codeletion status in isocitrate dehydrogenase mutation gliomas based on an Asian cohort: A narrative review
The expression of the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) can lead to tumor cell resistance to alkylating agents. Glioblastomas with isocitrate dehydrogenase mutation (IDHmut) were reported to have significantly higher MGMT promoter methylation, which predicted improved…
-
Artikel Jurnal
Initial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study
Background and Aim: High-grade glioma is the most common malignant primary brain tumor in the central nervous system. Multiple strategies such as surgery, radiotherapy, and chemotherapy have been used, but the prognosis of patients with high-grade glioma remains poor. No standard treatment exists…